May 19, 2020
May 19, 2020 —
Engineers at the University of California San Diego have developed a remote monitoring platform for patients who have tested positive for COVID-19 but aren’t in need of hospitalization. The system is being tested by patients in a clinical trial at UC San Diego Health.
May 15, 2020
May 15, 2020 —
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
May 14, 2020
May 14, 2020 —
The Rady School of Management at the University of California San Diego has launched the Rady School Business Recovery Coalition to help businesses in the San Diego region navigate the unprecedented challenges faced by COVID-19.
May 5, 2020
May 5, 2020 —
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.
May 5, 2020
May 5, 2020 —
With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic.
May 4, 2020
May 4, 2020 —
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
May 1, 2020
May 1, 2020 —
A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.
April 30, 2020
April 30, 2020 —
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
April 30, 2020
April 30, 2020 —
UC San Diego Health has been awarded double ‘A’ grades for the spring 2020 Leapfrog Hospital Safety Grade.
April 29, 2020
April 29, 2020 —
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
